Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM
Preliminary webcast agenda:
1. Announce topline data from the Phase 2 safety and immunogenicity trial in Older Adults
2. Provide additional findings from prior Phase 2 and Phase 3 clinical trials in Older Adults
3. Update on the Prepare™ trial for Infants via Maternal Immunization
Conference call details are as follows:
Date:
Time:
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode: 54820069
Webcast: www.novavax.com, "Investors"/ "Events"
Conference call and webcast replay:
Dates: Starting at
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode: 54820069
Webcast: www.novavax.com, "Investors"/ "Events", until
About
Contact:
Investor Relations
Director, Investor Relations
[email protected]
240-268-2000
[email protected]
443-213-0506
Media
[email protected]
[email protected]
212-845-4271
View original content:http://www.prnewswire.com/news-releases/novavax-to-host-an-rsv-f-vaccine-update-conference-call-and-webcast-on-july-24-2017-at-430-pm-300489222.html